Amgen (AMGN) Deferred Taxes (2016 - 2025)
Historic Deferred Taxes for Amgen (AMGN) over the last 13 years, with Q4 2025 value amounting to -$19.0 million.
- Amgen's Deferred Taxes rose 9431.14% to -$19.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$721.0 million, marking a year-over-year increase of 4128.66%. This contributed to the annual value of -$721.0 million for FY2025, which is 4128.66% up from last year.
- According to the latest figures from Q4 2025, Amgen's Deferred Taxes is -$19.0 million, which was up 9431.14% from -$30.0 million recorded in Q3 2025.
- In the past 5 years, Amgen's Deferred Taxes registered a high of -$19.0 million during Q4 2025, and its lowest value of -$623.0 million during Q4 2023.
- Over the past 5 years, Amgen's median Deferred Taxes value was -$250.5 million (recorded in 2022), while the average stood at -$243.6 million.
- In the last 5 years, Amgen's Deferred Taxes crashed by 71836.73% in 2024 and then soared by 9431.14% in 2025.
- Quarter analysis of 5 years shows Amgen's Deferred Taxes stood at -$189.0 million in 2021, then plummeted by 85.71% to -$351.0 million in 2022, then crashed by 77.49% to -$623.0 million in 2023, then surged by 46.39% to -$334.0 million in 2024, then skyrocketed by 94.31% to -$19.0 million in 2025.
- Its last three reported values are -$19.0 million in Q4 2025, -$30.0 million for Q3 2025, and -$422.0 million during Q2 2025.